What is the incidence of peripheral neuropathy in patients treated with bortezomib for TTP, and how does it affect treatment outcomes?

Bortezomib treatment can lead to significant peripheral neuropathy, affecting treatment outcomes, although the exact incidence rates vary widely. Treatment cessation or modifications can sometimes ameliorate symptoms, but specific data for bortezomib use in TTP is limited.